These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 27917698

  • 1. Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats.
    Wang L, Zhang HY, Gao B, Shi J, Huang Q, Han YH, Hu YQ, Lu WG, Zhao ZJ, Liu BH, Jie Q, Yang L, Luo ZJ.
    Stem Cells Dev; 2017 Mar 15; 26(6):419-430. PubMed ID: 27917698
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tetramethylpyrazine Protects Bone Marrow-Derived Mesenchymal Stem Cells against Hydrogen Peroxide-Induced Apoptosis through PI3K/Akt and ERK1/2 Pathways.
    Fang Y, Chu L, Li L, Wang J, Yang Y, Gu J, Zhang J.
    Biol Pharm Bull; 2017 Dec 01; 40(12):2146-2152. PubMed ID: 28978811
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti‑osteoporotic effects of tetramethylpyrazine via promoting osteogenic differentiation and inhibiting osteoclast formation.
    Wang L, Lu WG, Shi J, Zhang HY, Xu XL, Gao B, Huang Q, Li XJ, Hu YQ, Jie Q, Luo ZJ, Yang L.
    Mol Med Rep; 2017 Dec 01; 16(6):8307-8314. PubMed ID: 28983593
    [Abstract] [Full Text] [Related]

  • 6. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP, Mishra JS, Sharan K, Yadav M, Singh AK, Srivastava A, Kumar S, Bhaduaria S, Maurya R, Sanyal S, Chattopadhyay N.
    Phytomedicine; 2013 Nov 15; 20(14):1256-66. PubMed ID: 23928508
    [Abstract] [Full Text] [Related]

  • 7. Glucocorticoid-induced autophagy and apoptosis in bone.
    Wang T, Liu X, He C.
    Apoptosis; 2020 Apr 15; 25(3-4):157-168. PubMed ID: 32157482
    [Abstract] [Full Text] [Related]

  • 8. Autophagy as a target for glucocorticoid-induced osteoporosis therapy.
    Shen G, Ren H, Shang Q, Qiu T, Yu X, Zhang Z, Huang J, Zhao W, Zhang Y, Liang D, Jiang X.
    Cell Mol Life Sci; 2018 Aug 15; 75(15):2683-2693. PubMed ID: 29427075
    [Abstract] [Full Text] [Related]

  • 9. Preconditioning of bone marrow-derived mesenchymal stromal cells by tetramethylpyrazine enhances cell migration and improves functional recovery after focal cerebral ischemia in rats.
    Li L, Chu L, Fang Y, Yang Y, Qu T, Zhang J, Yin Y, Gu J.
    Stem Cell Res Ther; 2017 May 12; 8(1):112. PubMed ID: 28499457
    [Abstract] [Full Text] [Related]

  • 10. Pinocembrin alleviates glucocorticoid-induced apoptosis by activating autophagy via suppressing the PI3K/Akt/mTOR pathway in osteocytes.
    Wang XY, Gong LJ, Huang JM, Jiang C, Yan ZQ.
    Eur J Pharmacol; 2020 Aug 05; 880():173212. PubMed ID: 32470335
    [Abstract] [Full Text] [Related]

  • 11. Galangin mitigates glucocorticoid-induced osteoporosis by activating autophagy of BMSCs via triggering the PKA/CREB signaling pathway.
    Zeng C, Wang S, Gu H, Chen F, Wang Z, Li J, Xie Z, Feng P, Shen H, Wu Y.
    Acta Biochim Biophys Sin (Shanghai); 2023 Jun 26; 55(8):1275-1287. PubMed ID: 37365870
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Macrophage migration inhibitory factor induces autophagy to resist hypoxia/serum deprivation-induced apoptosis via the AMP-activated protein kinase/mammalian target of rapamycin signaling pathway.
    Xia W, Hou M.
    Mol Med Rep; 2016 Mar 26; 13(3):2619-26. PubMed ID: 26847932
    [Abstract] [Full Text] [Related]

  • 14. Gastrodin protects MC3T3-E1 osteoblasts from dexamethasone-induced cellular dysfunction and promotes bone formation via induction of the NRF2 signaling pathway.
    Liu S, Fang T, Yang L, Chen Z, Mu S, Fu Q.
    Int J Mol Med; 2018 Apr 26; 41(4):2059-2069. PubMed ID: 29393365
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis.
    Sui B, Hu C, Zhang X, Zhao P, He T, Zhou C, Qiu X, Chen N, Zhao X, Jin Y.
    Stem Cells Transl Med; 2016 Sep 26; 5(9):1238-46. PubMed ID: 27365487
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.